Axsome Therapeutics, Inc. - Common Stock (AXSM)

CUSIP: 05464T104

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / Common Stock
Shares outstanding
48,932,355
Total 13F shares
18,265,403
Share change
+3,562,579
Total reported value
$470,328,087
Put/Call ratio
46%
Price per share
$25.75
Number of holders
107
Value change
+$100,449,906
Number of buys
81
Number of sells
31

Quarterly Holders Quick Answers

What is CUSIP 05464T104?
CUSIP 05464T104 identifies AXSM - Axsome Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of AXSM - Axsome Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
RA CAPITAL MANAGEMENT, L.P.
13F
Company
6.7%
3,293,789
$46,871,000 31 Mar 2019
13F
BAKER BROS. ADVISORS LP
13F
Company
2.5%
1,200,000
$17,076,000 31 Mar 2019
13F
ALETHEA CAPITAL MANAGEMENT, LLC
13F
Company
2.3%
1,140,394
$16,228,000 31 Mar 2019
13F
VHCP Management III, LLC
13F
Company
2.2%
1,068,044
$15,198,000 31 Mar 2019
13F
Invesco Ltd.
13F
Company
2.1%
1,050,478
$14,948,000 31 Mar 2019
13F
VANGUARD GROUP INC
13F
Company
1.8%
901,787
$12,832,000 31 Mar 2019
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
1.6%
763,974
$10,871,000 31 Mar 2019
13F
RTW INVESTMENTS, LP
13F
Company
1.2%
595,635
$8,476,000 31 Mar 2019
13F
VHCP Management II, LLC
13F
Company
1.2%
571,956
$8,139,000 31 Mar 2019
13F
BlackRock Finance, Inc.
13F
Company
0.95%
465,587
$6,625,000 31 Mar 2019
13F
CWM, LLC
13F
Company
0.19%
91,417
$6,167,000 31 Mar 2019
13F
STIFEL FINANCIAL CORP
13F
Company
0.83%
404,145
$5,751,000 31 Mar 2019
13F
Ghost Tree Capital, LLC
13F
Company
0.63%
310,000
$4,411,000 31 Mar 2019
13F
Informed Momentum Co LLC
13F
Company
0.46%
227,241
$3,234,000 31 Mar 2019
13F
Laurion Capital Management LP
13F
Company
0.45%
219,000
$3,116,000 31 Mar 2019
13F
PURA VIDA INVESTMENTS, LLC
13F
Company
0.44%
213,645
$3,040,000 31 Mar 2019
13F
ROYCE & ASSOCIATES LP
13F
Company
0.37%
182,400
$2,596,000 31 Mar 2019
13F
Parallax Volatility Advisers, L.P.
13F
Company
0.34%
167,001
$2,376,000 31 Mar 2019
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.33%
162,454
$2,311,000 31 Mar 2019
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.26%
128,000
$1,821,000 31 Mar 2019
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.25%
124,500
$1,771,000 31 Mar 2019
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
0.19%
92,857
$1,321,000 31 Mar 2019
13F
MORGAN STANLEY
13F
Company
0.19%
90,683
$1,290,000 31 Mar 2019
13F
Bank of New York Mellon Corp
13F
Company
0.18%
87,841
$1,250,000 31 Mar 2019
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.18%
87,346
$1,243,000 31 Mar 2019
13F
Global IMC LLC
13F
Company
0.17%
85,086
$1,211,000 31 Mar 2019
13F
ALKEON CAPITAL MANAGEMENT LLC
13F
Company
0.16%
80,000
$1,138,000 31 Mar 2019
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.15%
74,265
$1,057,000 31 Mar 2019
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.14%
68,053
$968,000 31 Mar 2019
13F
Jefferies Group LLC
13F
Company
0.14%
67,788
$965,000 31 Mar 2019
13F
ExodusPoint Capital Management, LP
13F
Company
0.13%
62,772
$893,000 31 Mar 2019
13F
GROUP ONE TRADING LLC
13F
Company
0.11%
54,924
$782,000 31 Mar 2019
13F
PERCEPTIVE ADVISORS LLC
13F
Company
0.11%
53,879
$767,000 31 Mar 2019
13F
Endurant Capital Management LP
13F
Company
0.11%
52,268
$744,000 31 Mar 2019
13F
J. Goldman & Co LP
13F
Company
0.1%
46,973
$668,000 31 Mar 2019
13F
SEI INVESTMENTS CO
13F
Company
0.09%
43,645
$621,000 31 Mar 2019
13F
Sio Capital Management, LLC
13F
Company
0.09%
42,410
$603,000 31 Mar 2019
13F
Neuberger Berman Group LLC
13F
Company
0.09%
42,000
$598,000 31 Mar 2019
13F
PACIFIC VIEW ASSET MANAGEMENT, LLC
13F
Company
0.08%
39,921
$568,000 31 Mar 2019
13F
IRIDIAN ASSET MANAGEMENT LLC/CT
13F
Company
0.08%
37,130
$528,000 31 Mar 2019
13F
NORTHERN TRUST CORP
13F
Company
0.07%
35,358
$503,000 31 Mar 2019
13F
CITADEL ADVISORS LLC
13F
Company
0.07%
33,276
$474,000 31 Mar 2019
13F
Caption Management, LLC
13F
Company
0.06%
30,000
$427,000 31 Mar 2019
13F
BALDWIN WEALTH PARTNERS LLC/MA
13F
Company
0.06%
29,241
$416,000 31 Mar 2019
13F
Tibra Equities Europe Ltd
13F
Company
0.05%
22,404
$319,000 31 Mar 2019
13F
Mariner, LLC
13F
Company
0.04%
21,525
$306,000 31 Mar 2019
13F
SHANDA ASSET MANAGEMENT HOLDINGS Ltd
13F
Company
0.04%
19,958
$284,000 31 Mar 2019
13F
JANE STREET GROUP, LLC
13F
Company
0.04%
19,150
$273,000 31 Mar 2019
13F
CITIGROUP INC
13F
Company
0.04%
18,612
$265,000 31 Mar 2019
13F
Janney Montgomery Scott LLC
13F
Company
0.04%
17,575
$250,000 31 Mar 2019
13F

Institutional Holders of Axsome Therapeutics, Inc. - Common Stock (AXSM) as of Q2 2019

As of 30 Jun 2019, Axsome Therapeutics, Inc. - Common Stock (AXSM) was held by 107 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,265,403 shares. The largest 10 holders included BlackRock Inc., VHCP Management III, LLC, RA CAPITAL MANAGEMENT, LLC, ALETHEA CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, VHCP Management II, LLC, Ghost Tree Capital, LLC, RTW INVESTMENTS, LP, Invesco Ltd., and BAKER BROS. ADVISORS LP. This page lists 107 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders
64
Q2 2019 holders
107
Holder diff
43
Investor Q1 2019 Shares Q2 2019 Shares Share Diff Share Chg % Q1 2019 Value $ Q2 2019 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.